chesty Bodybuilding Competitor #61 You are building very nicely
P-21 What It Is: A small molecule mimetic of ciliary neurotrophic factor (CNTF) designed for neurogenesis and neuroprotection
GLP-1 agonists are promising for MASH treatment because they target multiple aspects of the disease, including fat accumulation, inflammation, and insulin resistance, which are all key factors in MASH progression
INJECTIBLE Hypoglycemic Drugs GLP-1 Analogs Exenatide ER Trade Names: Byetta (daily) Bydureon (weekly - extended release) Generic (Nov 2024) Drug Class: DPP-IV resistant Incretin (GLP-1 like) Mimetic Mechanism of Action: a synthetic analog of glucagon-like-polypeptide 1 (GLP-1) that is resistant to breakdown by DPP-IV
Brighter skin: regular use supports a more even, radiant complexion
Together, let's embark on this journey to better understand glutathione and its implications for our health and wellness